PARAGANGLIOMAS

Clinical trials for PARAGANGLIOMAS explained in plain language.

Never miss a new study

Get alerted when new PARAGANGLIOMAS trials appear

Sign up with your email to follow new studies for PARAGANGLIOMAS, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Trials to join now! 1

New 'Alpha' radiation therapy tested for Tough-to-Treat cancers

Disease control Recruiting now

This study is testing a new targeted radiation drug for adults whose gastrointestinal neuroendocrine tumors (GI NET) or adrenal tumors (pheochromocytoma/paragangliomas) have spread and cannot be removed by surgery, and have already been treated with a similar type of radiation th…

Matched conditions: PARAGANGLIOMAS

Phase: PHASE1, PHASE2 • Sponsor: National Cancer Institute (NCI) • Aim: Disease control

Last updated Mar 30, 2026 14:34 UTC

PARAGANGLIOMAS

Get alerted when new PARAGANGLIOMAS trials appear

New 'Alpha' radiation therapy tested for Tough-to-Treat cancers